Diabetes, particularly Type 2 Diabetes (T2DM), has been linked to an increased risk of various cancers, including liver, colorectal, and breast cancer.

Metabolic reprogramming in the tumor microenvironment shapes immune function and therapy resistance, offering insights into ...